Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - PIERIS PHARMACEUTICALS, INC.Financial_Report.xls
EX-14.1 - EX-14.1 - PIERIS PHARMACEUTICALS, INC.d889766dex141.htm
EX-32.2 - EX-32.2 - PIERIS PHARMACEUTICALS, INC.d889766dex322.htm
EX-10.8 - EX-10.8 - PIERIS PHARMACEUTICALS, INC.d889766dex108.htm
EX-31.2 - EX-31.2 - PIERIS PHARMACEUTICALS, INC.d889766dex312.htm
EX-10.9 - EX-10.9 - PIERIS PHARMACEUTICALS, INC.d889766dex109.htm
EX-31.1 - EX-31.1 - PIERIS PHARMACEUTICALS, INC.d889766dex311.htm
EX-10.4 - EX-10.4 - PIERIS PHARMACEUTICALS, INC.d889766dex104.htm
EX-10.10 - EX-10.10 - PIERIS PHARMACEUTICALS, INC.d889766dex1010.htm
10-K - 10-K - PIERIS PHARMACEUTICALS, INC.d889766d10k.htm
EX-10.7 - EX-10.7 - PIERIS PHARMACEUTICALS, INC.d889766dex107.htm

Exhibit 32.1

CERTIFICATIONS UNDER SECTION 906

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Pieris Pharmaceuticals, Inc. a Nevada corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

The Annual Report for the year ended December 31, 2014 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: March 27, 2015

/s/ Stephen S. Yoder

Stephen S. Yoder
Title: Chief Executive Officer and President
(principal executive officer)